Medtronic
Detect harm before it happens
Minneapolis, MN, US
Medtronic is a publicly traded medical technology company with four primary business units, serving patients and healthcare systems across more than 150 countries, with a focus on minimally invasive therapies, diabetes, restorative therapies, and cardiac and vascular solutions.
How We Help
Problem Statement
Medtronic addresses complex healthcare challenges and bridges gaps in patient care by pioneering solutions that improve outcomes and expand access to quality healthcare worldwide.
Core Technology
Medical Devices, AI, Engineering Expertise
Key Differentiators
Broad portfolio; Extensive global presence; Strong research and development capabilities; Strategy of acquiring innovative technologies; Emphasis on integrated care solutions; Leveraging data and AI
Clinical Focus
Interventional cardiology; Cardiac surgery; Neurology; Neurosurgery; Endocrinology; Diabetes education; Hospital administration
Company Info
- Business Model
- B2B
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
FDA-approved Symplicity Spyral renal denervation (2023). SPYRAL HTN-ON MED trial: -5.7 mmHg treatment difference vs sham at 24 months. DEFINE AFib study: 80% sensitivity for AFib detection before healthcare events. 2+ million patients on CareLink remote monitoring.
MedStartr Index Score
?What do you think of Medtronic?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.